- CEO
- Yongbo Yang
- Full Time Employees
- 551
- Sector
- Finance
- Industry
- Real estate development
- Address
- Building A4-4, Hanyu Financial and Business Center Jinan SD China 250101
- IPO Date
- Jan 3, 1994
- Business
- Jinan High-tech Development Co., Ltd. (600807.SS) is a China-based diversified company principally engaged in the in vitro diagnostics business, alongside real estate development, property services, trading, and other operations; it operates three main segments including the Real Estate and Property Services segment focused on real estate development, sales, property management, and leasing; the In Vitro Diagnostics segment encompassing research, development, production, and sales of molecular diagnostic reagents, molecular diagnostic automated testing equipment, biological sample library management software, biological sample intelligent storage cabinets, biological sample intelligent management terminals, and medical testing services primarily for infectious disease prevention and control, pathogenic microorganism detection, and food safety testing; and the Other Business segment covering trading activities such as steel rebar procurement and sales. The company also maintains involvement in industrial park investment, development, and operation; precious and non-ferrous metals exploration, mining, and processing including copper, lead, zinc, gold, and silver; property consulting and leasing; greening, landscaping, municipal engineering, garden design, and maintenance; agricultural machinery leasing; construction project quality inspection; equity investment; business management consulting; hotel management; and labor services, primarily targeting markets in China with operations centered in Shandong Province. Founded in 1993 and headquartered at 3F, Section A, Jinan International Convention & Exhibition Center, No. 1 Xinyu South Road, High-Tech Development Zone, Jinan, Shandong, China, the company employs approximately 565 people and lists on the Shanghai Stock Exchange. Recent developments include the wholly-owned subsidiary Shandong Ruifuxiang Trading Co., Ltd. signing a 2025-2026 Annual Steel Rebar Centralized Procurement Global Strategy Agreement with Jinan High-tech Development Group Co., Ltd. in August 2025; completion of a passive shareholding reduction by controlling shareholder affiliate Jinan Dongxin Construction and Development Co., Ltd. involving 1.21% of shares in July 2025; registration and establishment of Jinan Guangyao Industrial Investment and Development Partnership with approximately RMB 700 million investment; termination of a pastoral complex project; release of the 2025 semi-annual and third-quarter reports amid ongoing net losses; and continued emphasis on in vitro diagnostics products like molecular reagents and equipment alongside steel bars trading.